A detailed history of Spider Rock Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Spider Rock Advisors, LLC holds 12,506 shares of NVO stock, worth $1.09 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,506
Previous 15,230 17.89%
Holding current value
$1.09 Million
Previous $2.17 Million 31.48%
% of portfolio
0.02%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$119.07 - $145.42 $324,346 - $396,124
-2,724 Reduced 17.89%
12,506 $1.49 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $27,364 - $32,760
223 Added 1.49%
15,230 $2.17 Million
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $1.53 Million - $2.04 Million
15,007 New
15,007 $1.93 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.